Trial Outcomes & Findings for Effect of Music on the Sedative Use During Coronary Angioplasty (NCT NCT03817775)

NCT ID: NCT03817775

Last Updated: 2019-10-21

Results Overview

The consumption in Midazolam medication was reported during the coronary angioplasty. Dose was in mg.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

76 participants

Primary outcome timeframe

Between 10 minutes prior to the beginning of the procedure up to 45 minutes.

Results posted on

2019-10-21

Participant Flow

Participant milestones

Participant milestones
Measure
Control
The control group underwent coronary angiography without music intervention.
Music Therapy
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Overall Study
STARTED
22
54
Overall Study
COMPLETED
22
54
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=22 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=54 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Total
n=76 Participants
Total of all reporting groups
Age, Continuous
62.4 years
STANDARD_DEVIATION 13.37 • n=22 Participants
67.2 years
STANDARD_DEVIATION 9.07 • n=54 Participants
65.7 years
STANDARD_DEVIATION 10.68 • n=76 Participants
Sex: Female, Male
Female
4 Participants
n=22 Participants
6 Participants
n=54 Participants
10 Participants
n=76 Participants
Sex: Female, Male
Male
18 Participants
n=22 Participants
48 Participants
n=54 Participants
66 Participants
n=76 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
France
22 participants
n=22 Participants
54 participants
n=54 Participants
76 participants
n=76 Participants
ASA Score
Normal: Score 1
2 Participants
n=22 Participants
0 Participants
n=54 Participants
2 Participants
n=76 Participants
ASA Score
Moderate abnormality: Score 2
3 Participants
n=22 Participants
5 Participants
n=54 Participants
8 Participants
n=76 Participants
ASA Score
Severe abnormality: Score 3
16 Participants
n=22 Participants
45 Participants
n=54 Participants
61 Participants
n=76 Participants
ASA Score
Missing
1 Participants
n=22 Participants
4 Participants
n=54 Participants
5 Participants
n=76 Participants

PRIMARY outcome

Timeframe: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.

The consumption in Midazolam medication was reported during the coronary angioplasty. Dose was in mg.

Outcome measures

Outcome measures
Measure
Control
n=22 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=54 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Dose Use of Midazolam Medication (mg)
3.0 mg
Standard Deviation 0.84
1.2 mg
Standard Deviation 0.76

PRIMARY outcome

Timeframe: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.

Population: One patient in control group and 2 patients in music therapy group had missing data on Propofol medication.

The consumption in Propofol medication was reported during the coronary angioplasty. Dose was in mg.

Outcome measures

Outcome measures
Measure
Control
n=21 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=52 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Dose Use of Propofol Medication (mg)
12.8 mg
Standard Deviation 21.83
52 mg
Standard Deviation 0

PRIMARY outcome

Timeframe: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.

The consumption in Sufentanil medication was reported during the coronary angioplasty. Dose was in ug.

Outcome measures

Outcome measures
Measure
Control
n=22 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=54 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Dose Use of Sufentanil Medication (ug)
4.9 ug
Standard Deviation 1.21
5.1 ug
Standard Deviation 1.02

SECONDARY outcome

Timeframe: From 0 up to 45 minutes.

Population: Three patients in control group and 3 patients in music therapy group had missing data on VAS pain score.

Pain score was measured using the Visual Analog Scale (VAS). This scale ranged from 0 (no pain) to 10 (very high pain), and collected the maximum pain the patient had during the procedure. This was collected right after the end of the procedure in the recovery room.

Outcome measures

Outcome measures
Measure
Control
n=19 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=51 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Pain Score
0.5 score on a scale
Standard Deviation 0.70
0.7 score on a scale
Standard Deviation 1.47

SECONDARY outcome

Timeframe: From 0 up to 45 minutes.

Anxiety score was measured using the Numeric Rating Scale (NRS). This scale ranged from 0 (no anxiety) to 10 (very high anxiety), and collected the maximum anxiety the patient had during the procedure. This was collected right after the end of the procedure in the recovery room.

Outcome measures

Outcome measures
Measure
Control
n=21 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=53 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Anxiety Score (NRS)
4.2 score on a scale
Standard Deviation 1.89
2.9 score on a scale
Standard Deviation 2.19

SECONDARY outcome

Timeframe: Right after the end of the procedure in the recovery room.

Population: Two patients in control group and 3 patients in music therapy group had missing data on satisfaction endpoint.

Satisfaction was measured using a scale from 0 to 5, with a higher score for a high satisfaction.

Outcome measures

Outcome measures
Measure
Control
n=20 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=51 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Satisfaction of the Patient
4.5 Score
Standard Deviation 0.51
4.8 Score
Standard Deviation 0.44

SECONDARY outcome

Timeframe: 10 minutes prior to the beginning of the procedure

Population: 2 missing data in control group

Bispectral index (BIS) score at baseline which corresponds to 10 minutes before the beginning of the procedure. The BIS monitor provides a single dimensionless number which ranges from 0 (equivalent to EEG silence) to 100. Higher is the score, better it is.

Outcome measures

Outcome measures
Measure
Control
n=20 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=54 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Effect on Physiological Parameters: BIS
96.9 Score
Standard Deviation 2.1
94.9 Score
Standard Deviation 5.5

SECONDARY outcome

Timeframe: 10 minutes prior to the beginning of the procedure.

Heart rate at Baseline which corresponds to 10 minutes before the beginning of the procedure.

Outcome measures

Outcome measures
Measure
Control
n=22 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=54 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Effect on Physiological Parameters: Heart Rate
71.3 beat/min
Standard Deviation 13.1
65.5 beat/min
Standard Deviation 11.4

SECONDARY outcome

Timeframe: 10 minutes prior to the beginning of the procedure.

SpO2 at Baseline which corresponds to 10 minutes before the beginning of the procedure..

Outcome measures

Outcome measures
Measure
Control
n=22 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=54 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Effect on Physiological Parameters: SpO2%
98.5 Percentage of O2 saturation in blood
Standard Deviation 1.4
98.9 Percentage of O2 saturation in blood
Standard Deviation 1.3

SECONDARY outcome

Timeframe: 10 minutes prior to the beginning of the procedure.

Population: Two patients in control group and 1 in music therapy had missing data.

Mean arterial blood pressure at Baseline which corresponds to 10 minutes before the beginning of the procedure.

Outcome measures

Outcome measures
Measure
Control
n=20 Participants
The control group underwent coronary angiography without music intervention.
Music Therapy
n=53 Participants
The intervention group also underwent coronary angiography and administered music therapy between 10 minutes prior to the beginning of the procedure until its end. Music therapy: The intervention group administered "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
Effect on Physiological Parameters: Mean Arterial Blood Pressure
104.7 mmHg
Standard Deviation 14.1
104.2 mmHg
Standard Deviation 17.2

Adverse Events

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Music Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Gilles BOCCARA

• Department of Anaesthesia and Intensive Care, American Hospital of Paris

Phone: +33 1 46 41 25 25

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place